Skip to main content
Navigate Up
Sign In

Thyroid Hormone Suppression Therapy – Less is More for Thyroid Cancer

For endocrinologists, Bryan Haugen, professor of medicine and pathology, and head of the division of endocrinology, metabolism and diabetes at CU, said the bottom line is that “one size thyroid hormone therapy and TSH target ranges does not fit all differentiated thyroid cancer patients. The TSH target should be based on the severity of the disease and most importantly, the response to therapy weighted against the individual’s risk factors for taking excess thyroid hormone therapy.”

EndocrineWeb, April 26, 2019

Read more